ArticleJACC. Case reports2025

Apparent Nonresponse to PCSK9 Inhibition in a Patient With Heterozygous Familial Hypercholesterolemia Due to PCSK9 Gene Duplication.

Mustansir Pindwarawala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.